FBXO38 Activators
FBXO38, a member of the F-box family of proteins, is intricately regulated by multiple signaling pathways that alter its ubiquitin ligase activity through post-translational modifications, primarily phosphorylation. Compounds that elevate intracellular cAMP or cGMP levels serve as indirect activators of FBXO38 by stimulating protein kinases A and G, respectively. These kinases can target a myriad of substrates, including those associated with FBXO38, leading to a change in its activity or substrate affinity. Additionally, direct activation of protein kinase C through diacylglycerol analogs initiates a distinct phosphorylation cascade that could converge on FBXO38 or its substrates, potentially modulating its recognition and ubiquitination functions. The inhibition of protein phosphatases results in a general increase in phosphorylated proteins within the cell, some of which may interact with FBXO38, thereby influencing its ubiquitination activity.
Other signaling molecules that indirectly impact FBXO38 activity include growth factors such as EGF, which through their receptor tyrosine kinases, initiate a series of phosphorylation events that can alter FBXO38 function. The PI3K/AKT signaling pathway, commonly activated by insulin, plays a significant role in cellular growth and metabolism and could lead to modifications in FBXO38 activity by altering the phosphorylation status of proteins within its scope. Similarly, the MAPK/ERK pathway, activated by mitogens and various growth factors, can also affect FBXO38. This pathway is involved in the regulation of cell proliferation and differentiation, and its downstream effectors may phosphorylate FBXO38 or its regulatory proteins, affecting the protein's stability, localization, or ligase activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
As a non-selective inhibitor of phosphodiesterases, IBMX leads to elevated cAMP and cGMP levels, thus enhancing PKA and PKG activities which can augment the phosphorylation of proteins that associate with FBXO38, potentially increasing its activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
This phorbol ester activates protein kinase C, which can phosphorylate regulatory proteins or substrates of FBXO38, modifying its recognition and ubiquitination of target proteins. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
The binding of insulin to its receptor activates the PI3K/AKT pathway, which can lead to the phosphorylation of proteins that interact with FBXO38, influencing its substrate specificity and activity. | ||||||
Sodium Fluoride | 7681-49-4 | sc-24988A sc-24988 sc-24988B | 5 g 100 g 500 g | $40.00 $46.00 $100.00 | 26 | |
This G-protein activator can initiate a cascade that activates kinases capable of phosphorylating FBXO38 or its partner proteins, potentially enhancing its ubiquitin ligase function. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
As an inhibitor of serine/threonine protein phosphatases, okadaic acid can increase the phosphorylation state of proteins within the cell, which might include FBXO38 or its associated proteins, thereby stimulating its activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
This calcium ionophore elevates intracellular calcium, which could activate calmodulin-dependent kinases. These kinases may phosphorylate FBXO38 or its substrates, increasing its enzymatic activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium inhibits glycogen synthase kinase-3, which may lead to alterations in Wnt signaling pathway components that interact with FBXO38, consequently affecting its ubiquitination activity. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
This cell-permeable cAMP analog directly activates PKA, potentially leading to enhanced phosphorylation of FBXO38 or its substrate proteins, thus increasing its ubiquitin ligase activity. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
As an inhibitor of protein phosphatases, calyculin A leads to increased phosphorylation levels of cellular proteins, which may include those that regulate or modify the activity of FBXO38. | ||||||